Clinical Trial Update: Virtual Reality & D-cycloserine (DCS) for Posttraumatic Stress Disorder (PTSD) [NA]

View source ↗

Summary

This trial evaluated virtual reality exposure therapy for PTSD with D-cycloserine as an augmenting drug; the study is completed and results were posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Posttraumatic Stress Disorder

Drugs mentioned

• D-cycloserine (D-cycloserine)

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Posttraumatic Stress Disorder | NA | Status: COMPLETED | Results posted: 2015-08-27